REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. Seer’s management is scheduled to participate in a fireside chat on Tuesday, September 9th at 12:20 p.m. Eastern Time / 9:20 a.m. Pacific Time. A live webcast of the session will be available on the Investor sectio ...

Group 1 - Lesaka Technologies, Inc. plans to release its fourth quarter and year-end 2025 results after the U.S. market close on September 10, 2025 [1] - A presentation webcast and conference call will be hosted by Lesaka management on September 11, 2025, at 8:00am EDT, followed by a live Q&A session for analysts and investors [1] - An archived version of the webcast will be available on Lesaka's Investor Relations website after the presentation [4] Group 2 - Lesaka operates as a South African fintech company, providing financial services, software, and business services to underserved consumers and merchants in Southern Africa [4] - The company offers an integrated multiproduct platform that includes transactional accounts, lending, insurance, merchant acquiring, cash management, software, and Alternative Digital Payments (ADP) [4] - Lesaka has a primary listing on NASDAQ and a secondary listing on the Johannesburg Stock Exchange [5]

Core Insights - 3D Systems has been awarded a $7.65 million contract by the U.S. Air Force for the development of a Large-format Metal 3D Printer Advanced Technology Demonstrator [1] - This contract is part of a program that 3D Systems has been involved in since 2023, focusing on large-scale, high-speed additive manufacturing capabilities [1][2] - The project will be executed at the company's facilities in San Diego, California, and Rock Hill, South Carolina, with an expected completion date of September 27, 2027 [1] Company Background - 3D Systems has a history of collaboration with the U.S. Department of Defense since 2019, aimed at advancing additive manufacturing technologies [2] - The company has been a pioneer in the 3D printing industry for nearly 40 years, founded by Chuck Hull, and continues to innovate in various high-value markets including aerospace, medical, and durable goods [4] - The company aims to transform manufacturing through its industry-leading 3D printing technologies, materials, and software [4]

ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring and infusion systems, today announced that it will participate in the Wells Fargo 2025 Healthcare Conference, held September 3-5, 2025, in Boston, Massachusetts. Roger Susi, President and CEO, and Jack Glenn, CFO, will host 1x1 investor meetings at the 2025 Wells Fargo Healthcare Conference on September 4, 2025, in B ...

Summary of Key Points Core Viewpoint - The total short interest in Nasdaq securities has increased, indicating a growing bearish sentiment among investors as of the settlement date of August 15, 2025 Group 1: Nasdaq Global Market - Short interest in 3,302 Nasdaq Global Market securities totaled 13,965,671,937 shares, up from 13,683,072,188 shares in the previous period [1] - The mid-August short interest represents an average of 2.34 days, compared to 2.15 days in the prior reporting period [1] Group 2: Nasdaq Capital Market - Short interest in 1,665 securities on The Nasdaq Capital Market reached 2,964,394,253 shares, an increase from 2,910,549,464 shares in the previous period [2] - The average daily volume for this period remained at 1.00 day, consistent with the previous reporting period [2] Group 3: Overall Nasdaq Securities - Total short interest across all 4,967 Nasdaq securities amounted to 16,930,066,190 shares, compared to 16,593,621,652 shares in the prior period [3] - This represents an average of 1.86 days of daily volume, up from 1.56 days in the previous reporting period [3] Group 4: Short Sale Definition - A short sale is defined as the sale of a security that the seller does not own or any sale consummated by the delivery of a borrowed security [4]

Core Viewpoint - Sana Biotechnology, Inc. is set to present at four investor conferences in September 2025, providing a business overview and updates on its engineered cell therapies [1][5]. Company Overview - Sana Biotechnology focuses on creating engineered cells as medicines, aiming to repair and control genes, and replace missing or damaged cells [3]. - The company operates in Seattle, WA, Cambridge, MA, and South San Francisco, CA [3]. Upcoming Events - Sana will present at the following conferences: - Citi's 2025 Biopharma Back-to-School Conference on September 2, 2025, at 3:15 p.m. ET [5]. - 2025 Wells Fargo Healthcare Conference on September 4, 2025, at 8:00 a.m. ET [5]. - Morgan Stanley 23 Annual Global Healthcare Conference on September 8, 2025, at 11:30 a.m. ET [5]. - HC Wainwright 27 Annual Global Investment Conference on September 9, 2025, at 9:30 a.m. ET [5]. Investor Relations - Webcasts of the presentations will be available on the Investor Relations page of Sana's website, with replays accessible for 30 days post-conference [2].

Core Insights - Matrix Service Company will release its fourth quarter and full-year Fiscal 2025 results on September 9, 2025, after market close [1] - A conference call to discuss the financial results and forward outlook is scheduled for September 10, 2025, at 10:30 a.m. Eastern time [2] Company Overview - Matrix Service Company is a leading North American industrial engineering, construction, and maintenance contractor, headquartered in Tulsa, Oklahoma, with offices across the United States, Canada, Australia, and South Korea [4] - The company operates in three key segments: Utility and Power Infrastructure, Process and Industrial Facilities, and Storage and Terminal Solutions [5] Sustainability and Recognition - The company emphasizes sustainability and strong Environment, Social, and Governance (ESG) practices, ranking among the Top Contractors by Engineering-News Record and recognized for Board diversification [6]

SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. Management will be hosting a fireside chat on Tuesday, September 9, 2025, at 4:00 a.m. Pacific Time/ 07:00 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at thi ...

Company Overview - DeFi Development Corp. (Nasdaq: DFDV) has a treasury policy that allocates its principal holding to Solana (SOL), providing investors with direct economic exposure to SOL while participating in the growth of the Solana ecosystem [3] - The company operates its own validator infrastructure, generating staking rewards and fees from delegated stake, and is engaged in decentralized finance (DeFi) opportunities [3] - DeFi Development Corp. serves over one million web users annually, including property owners, developers, and various lenders, applying for billions of dollars in debt financing each year [5] Recent Developments - The company announced a live X Spaces event scheduled for August 27, 2025, at 4:30 PM ET, featuring insights into a recently announced $125 million equity raise [1][7] - The event will cover the structure of the equity raise, the rationale behind it, intended use of proceeds, and the company's role in expanding Solana adoption [7] Business Model - The company's data and software offerings are primarily provided on a subscription basis as software as a service (SaaS), catering to the commercial real estate industry [4][5] - DeFi Development Corp. connects stakeholders in the commercial real estate ecosystem, providing data and software subscriptions along with value-added services [4]

Core Points - Cognition Therapeutics, Inc. has regained compliance with Nasdaq's minimum share price requirement under Rule 5550(a)(2) [1][2] - The company achieved a minimum closing bid price of $1.00 or more for at least 10 consecutive business days, with the requirement fulfilled on August 25, 2025 [2] - Cognition Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecule therapeutics for neurodegenerative disorders [3] Company Overview - Cognition Therapeutics is currently developing zervimesine (CT1812), targeting dementia with Lewy bodies, mild-to-moderate Alzheimer's disease, and geographic atrophy secondary to dry AMD [3] - The Phase 2 START study in early Alzheimer's disease is ongoing, supported by $81 million in grants from the National Institute of Aging [3] - The mechanism of zervimesine involves interaction with the sigma-2 receptor, which is distinct from other treatment approaches for degenerative diseases [3]